Pharmaceutical Sales 2006

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2006, listed by U.S. sales value and brand name.
New: Quarterly Top 100 prescription sales data now available, from Q1 2011 more....

Top 200 Drugs for 2006 by Sales

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2005
1 Lipitor Pfizer Inc 6,577,810 4.1%
2 Nexium AstraZeneca Pharmaceuticals 4,060,286 18.1%
3 Prevacid Takeda Pharmaceuticals North America, Inc 3,305,778 -0.7%
4 (1) Advair Diskus GlaxoSmithKline 3,105,780 9.7%
5 (4) Singulair Merck & Co., Inc. 2,460,929 17.8%
6 (2) Effexor XR Pfizer Inc 2,246,965 1.2%
7 Plavix Bristol-Myers Squibb Company 2,231,825 -10.0%
8 (4) Zocor Merck & Co., Inc. 2,171,312 -30.1%
9 (1) Norvasc Pfizer Inc 2,149,017 4.3%
10 (3) Lexapro Forest Pharmaceuticals, Inc 2,098,794 13.5%
11 (3) Seroquel AstraZeneca Pharmaceuticals 2,074,734 20.7%
12 (1) Protonix Wyeth 2,020,865 3.2%
13 (1) Ambien Pfizer Inc 1,938,649 0.3%
14 (1) Actos Takeda Pharmaceuticals North America, Inc 1,926,293 20.0%
15 (9) Zoloft Pfizer Inc 1,772,599 -30.8%
16 (5) Wellbutrin XL Valeant Pharmaceuticals International 1,670,516 26.0%
17 (2) Avandia GlaxoSmithKline 1,664,459 20.5%
18 Risperdal Janssen Pharmaceuticals, Inc 1,656,891 12.5%
19 (3) Zyprexa Eli Lilly and Company 1,536,167 -2.6%
20 (5) Topamax Janssen Pharmaceuticals, Inc 1,520,472 19.9%
21 (2) Toprol XL AstraZeneca Pharmaceuticals 1,471,881 13.7%
22 (27) Vytorin Merck & Co., Inc. 1,469,209 105.4%
23 (6) Fosamax Merck & Co., Inc. 1,427,165 -3.8%
24 (5) Abilify Bristol-Myers Squibb Company 1,417,106 29.0%
25 (5) Levaquin Janssen Pharmaceuticals, Inc 1,409,195 4.5%
26 (8) Lamictal GlaxoSmithKline 1,326,844 28.7%
27 (1) Celebrex Pfizer Inc 1,326,177 6.0%
28 Lotrel Novartis Corporation 1,292,863 16.5%
29 (2) Zyrtec Johnson & Johnson 1,163,312 10.0%
30 (11) Coreg GlaxoSmithKline 1,158,322 36.8%
31 (5) Valtrex GlaxoSmithKline 1,150,247 17.6%
32 (7) Zetia Merck & Co., Inc. 1,139,638 26.0%
33 (2) Adderall XR Shire US Inc 1,131,834 12.3%
34 (2) Aciphex Eisai Corporation 1,113,022 6.2%
35 (26) Cymbalta Eli Lilly and Company 1,084,313 90.1%
36 (9) Enbrel Amgen Inc. 1,084,243 -4.1%
37 (14) Crestor AstraZeneca Pharmaceuticals 1,058,160 56.3%
38 (8) Lantus Sanofi (formerly Sanofi Aventis) 1,057,914 36.6%
39 (4) Diovan Novartis Corporation 972,055 19.9%
40 (5) Tricor Abbott Laboratories 965,680 22.4%
41 (1) Concerta Johnson & Johnson 936,240 8.1%
42 (6) Diovan HCT Novartis Corporation 866,738 19.7%
43 (1) Imitrex Oral GlaxoSmithKline 858,252 4.6%
44 (8) Aricept Eisai Corporation 799,967 22.7%
45 (10) Nasonex Merck & Co., Inc. 788,998 26.9%
46 (1) Viagra Pfizer Inc 786,142 1.8%
47 (12) Flomax Boehringer Ingelheim Pharmaceuticals, Inc 785,626 34.7%
48 (4) Actonel Procter & Gamble 780,529 -1.5%
49 (9) Omnicef Abbott Laboratories 772,826 27.2%
50 Altace King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 717,207 2.4%
51 (27) OxyContin Purdue Pharma LP 682,904 -46.9%
52 () Lyrica Pfizer Inc 650,944 930.3%
53 (11) Zofran GlaxoSmithKline 645,411 16.3%
54 (14) Provigil Cephalon, Inc. 644,528 29.7%
55 (16) Lidoderm Endo Pharmaceuticals 635,892 35.1%
56 (4) Cozaar Merck & Co., Inc. 618,670 6.6%
57 Lamisil Oral Novartis Corporation 613,006 0.7%
58 (19) Lovenox Sanofi (formerly Sanofi Aventis) 596,680 36.0%
59 (38) Spiriva Boehringer Ingelheim Pharmaceuticals, Inc 593,334 75.6%
60 (5) Detrol LA Pfizer Inc 584,532 9.3%
61 (56) Lunesta Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 583,556 120.8%
62 (8) Synthroid Abbott Laboratories 579,742 -9.4%
63 (10) Strattera Eli Lilly and Company 577,944 -10.0%
64 (8) Premarin Tabs Wyeth 576,358 -6.5%
65 (43) Pravachol Bristol-Myers Squibb Company 575,985 -56.2%
66 (33) Truvada Gilead Sciences, Inc. 569,618 74.4%
67 () Ambien CR Sanofi (formerly Sanofi Aventis) 552,980 >999
68 (21) Actiq Abbott Laboratories 546,427 47.4%
69 (6) Depakote Abbott Laboratories 542,016 -3.8%
70 (3) Combivent Boehringer Ingelheim Pharmaceuticals, Inc 534,477 6.6%
71 (1) Humalog Eli Lilly and Company 533,683 10.1%
72 (9) Geodon Oral Pfizer Inc 529,350 24.8%
73 (4) Pulmicort Respules AstraZeneca Pharmaceuticals 520,747 7.1%
74 (1) Trileptal Novartis Corporation 513,429 12.0%
75 (37) Mobic Abbott Laboratories 512,978 -44.0%
76 Yasmin 28 Bayer Healthcare Pharmaceuticals 508,160 15.2%
77 (11) Evista Eli Lilly and Company 507,954 0.6%
78 (6) CellCept Roche Pharmaceuticals 507,652 9.9%
79 (5) Humira Abbott Laboratories 505,566 28.0%
80 (1) Depakote ER Abbott Laboratories 501,961 17.2%
81 (7) Keppra UCB Inc. 498,913 31.4%
82 (7) Skelaxin Elan Corporation 482,964 8.4%
83 (26) Flovent HFA GlaxoSmithKline 476,624 64.6%
84 (10) Hyzaar Merck & Co., Inc. 474,967 6.0%
85 (2) Niaspan Abbott Laboratories 473,755 24.4%
86 (8) Prograf Astellas Pharma US 446,139 3.4%
87 (6) Arimidex AstraZeneca Pharmaceuticals 446,009 28.2%
88 (3) Procrit Centocor Ortho Biotech, Inc 418,431 6.3%
89 (11) Zelnorm Novartis Corporation 417,116 31.1%
90 (8) Xalatan Pfizer Inc 403,790 -1.3%
91 (5) Asacol Procter & Gamble 388,196 14.5%
92 (20) Namenda Forest Pharmaceuticals, Inc 386,739 36.5%
93 (13) Cialis Eli Lilly and Company 375,143 27.1%
94 (7) Reyataz Bristol-Myers Squibb Company 372,790 18.8%
95 Ortho Tri-Cyclen Lo Ortho-McNeil-Janssen Pharmaceuticals, Inc. 371,803 9.6%
96 (4) Avapro Bristol-Myers Squibb Company 367,239 4.7%
97 () Byetta Amylin Pharmaceuticals, Inc. 362,996 632.3%
98 (36) Duragesic Johnson & Johnson 357,439 -37.3%
99 (13) Combivir GlaxoSmithKline 355,848 -9.4%
100 (11) Kaletra Abbott Laboratories 352,013 23.6%
101 (14) Gleevec Novartis Corporation 338,139 24.8%
102 (20) Avelox Bayer Healthcare Pharmaceuticals 335,397 29.3%
103 (20) Allegra-D 12 Hour Sanofi (formerly Sanofi Aventis) 335,011 -15.8%
104 (27) Benicar HCT Daiichi Sankyo 333,894 46.8%
105 (7) Paxil CR Apotex Corp 327,010 -1.5%
106 (15) Clarinex Merck & Co., Inc. 321,246 -9.1%
107 Xopenex Sepracor Inc. (renamed Sunovion Pharmaceuticals Inc) 320,084 9.2%
108 (18) Benicar Daiichi Sankyo 312,791 24.4%
109 (1) Copaxone Sanofi (formerly Sanofi Aventis) 305,828 7.0%
110 (7) Sustiva Bristol-Myers Squibb Company 300,944 -2.7%
111 (5) Avalide Bristol-Myers Squibb Company 300,774 12.2%
112 (10) Nasacort AQ Sanofi (formerly Sanofi Aventis) 299,484 -3.8%
113 (8) AndroGel Abbott Laboratories 295,593 13.3%
114 (4) Forteo Eli Lilly and Company 295,172 11.9%
115 (2) Patanol Alcon Laboratories, Inc. 290,912 4.8%
116 (8) Avonex Biogen Idec 289,082 -1.2%
117 (84) Flonase GlaxoSmithKline 285,179 -72.7%
118 (16) Thalomid Celgene Corporation 273,921 25.7%
119 () Boniva Genentech, Inc (member of Roche group) 270,321 387.8%
120 (16) Zofran ODT GlaxoSmithKline 267,379 24.9%
121 (76) Caduet Pfizer Inc 266,446 91.3%
122 () Requip GlaxoSmithKline 260,813 139.5%
123 (10) Fuzeon Roche Pharmaceuticals 256,183 15.8%
124 (20) Rhinocort Aqua AstraZeneca Pharmaceuticals 254,697 -14.1%
125 (5) Norvir Abbott Laboratories 249,522 8.0%
126 (55) Tarceva Genentech, Inc (member of Roche group) 245,470 64.2%
127 (22) Ditropan XL Janssen Pharmaceuticals, Inc 244,579 -17.4%
128 (4) Aldara Medicis Pharmaceutical Corporation 242,947 7.1%
129 (46) NovoLog Mix 70/30 Novo Nordisk Inc. 238,014 53.5%
130 (24) Femara Novartis Corporation 237,495 37.0%
131 (51) Ortho Evra Ortho-McNeil-Janssen Pharmaceuticals, Inc. 232,914 -45.2%
132 (18) Endocet Endo Pharmaceuticals 226,805 25.3%
133 (13) RenaGel Genzyme Corporation 226,128 22.2%
134 (9) Cosopt Merck & Co., Inc. 223,797 17.5%
135 (21) Viread Gilead Sciences, Inc. 223,659 -17.7%
136 (11) Trizivir GlaxoSmithKline 222,562 -12.3%
137 (8) Budeprion SR Teva Pharmaceuticals 211,097 -10.0%
138 (50) Restasis Allergan, Inc 208,568 42.3%
139 (29) Zyvox Pfizer Inc 204,629 26.1%
140 (29) Relpax Pfizer Inc 204,508 26.2%
141 (20) Lumigan Allergan, Inc 203,641 21.3%
142 (2) BenzaClin Sanofi (formerly Sanofi Aventis) 203,033 2.2%
143 (2) Humalog Mix 75/25 Pn 200,266 3.9%
144 (50) Zithromax Susp 198,939 -41.9%
145 (10) Mirapex Boehringer Ingelheim Pharmaceuticals, Inc 197,457 15.0%
146 () Avodart GlaxoSmithKline 192,791 99.7%
147 (15) Casodex AstraZeneca Pharmaceuticals 192,647 15.0%
148 (44) Astelin Meda Pharmaceuticals 186,944 29.6%
149 (37) Vigamox Alcon Laboratories, Inc. 181,807 23.3%
150 () Epzicom GlaxoSmithKline 181,391 64.2%
151 (13) Lescol XL Novartis Corporation 180,223 -13.6%
152 (18) Xeloda Genentech, Inc (member of Roche group) 179,612 10.9%
153 (4) Tussionex Sanofi (formerly Sanofi Aventis) 179,383 -1.2%
154 (17) Coumadin Tabs Bristol-Myers Squibb Company 178,711 -14.8%
155 () Sensipar Amgen Inc. 177,838 89.1%
156 (38) Levitra Bayer Healthcare Pharmaceuticals 177,367 25.3%
157 (2) Temodar Merck & Co., Inc. 177,089 5.2%
158 (6) Inderal LA Wyeth 175,218 -1.4%
159 (12) Prilosec AstraZeneca Pharmaceuticals 174,624 -5.1%
160 (7) Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc 174,137 6.8%
161 () NuvaRing Merck & Co., Inc. 173,168 55.0%
162 (38) Biaxin XL Abbott Laboratories 171,873 -32.6%
163 (18) Zyrtec Syrup 171,381 -8.2%
164 (16) Alphagan P Allergan, Inc 169,571 -7.5%
165 (9) Differin Galderma Laboratories 168,884 0.0%
166 (1) Zyrtec-D Pfizer Inc 168,028 2.7%
167 (7) Tobradex Alcon Laboratories, Inc. 166,663 7.5%
168 (19) Aranesp Amgen Inc. 166,443 13.2%
169 (16) Klor-Con Upsher-Smith Laboratories Inc. 163,286 -7.1%
170 (12) Humulin N Eli Lilly and Company 163,208 -3.1%
171 DuoNeb Dey Pharma 162,376 0.7%
172 (6) Famvir GlaxoSmithKline 160,602 -1.7%
173 (45) Proscar Merck & Co., Inc. 160,135 -33.0%
174 (8) Neupogen Amgen Inc. 159,279 7.1%
175 (48) Elidel Novartis Corporation 159,248 -36.4%
176 () Focalin XR Novartis Corporation 159,008 320.2%
177 (35) Levoxyl King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 158,100 -17.4%
178 Betaseron Bayer Healthcare Pharmaceuticals 157,966 3.9%
179 () Ciprodex Otic Alcon Laboratories, Inc. 157,513 20.1%
180 (36) Trinessa Watson Pharmaceuticals, Inc. (now Actavis, Inc) 157,403 -15.8%
181 (2) Atacand AstraZeneca Pharmaceuticals 156,519 5.4%
182 (18) Pegasys Genentech, Inc (member of Roche group) 154,897 -5.8%
183 () Kadian Actavis 154,653 40.5%
184 (21) Arthrotec Pfizer Inc 152,627 -7.3%
185 () Aggrenox Boehringer Ingelheim Pharmaceuticals, Inc 151,976 20.1%
186 (7) Humulin 70/30 Eli Lilly and Company 149,664 5.1%
187 (13) Avinza King Pharmaceuticals, Inc. (now part of Pfizer - October 2010) 149,425 10.7%
188 (2) Pulmozyme Genentech, Inc (member of Roche group) 145,461 -0.4%
189 () Travatan Alcon Laboratories, Inc. 144,801 24.4%
190 () Maxalt Merck & Co., Inc. 144,387 17.7%
191 () Dovonex Bristol-Myers Squibb Company 143,568 7.9%
192 () Risperdal Consta Janssen Pharmaceuticals, Inc 142,446 28.2%
193 () Tri-Sprintec 140,810 9.7%
194 (5) Zomig AstraZeneca Pharmaceuticals 140,265 -4.0%
195 () Maxalt MLT 140,005 12.4%
196 (2) Prempro Pfizer Inc 138,795 1.6%
197 (58) Augmentin XR Dr. Reddy's Laboratories Inc. 138,544 -32.8%
198 () Suboxone Reckitt Benckiser Pharmaceuticals Inc. 137,067 93.5%
199 (79) Avandamet GlaxoSmithKline 136,470 -47.9%
200 () Fosamax Plus D Merck & Co., Inc. 136,034 506.5%
All Others 23,603,372 -12.7%

Source: Verispan, VONA

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Hide
(web2)